Knockout of p75NTR ligand- binding domain decreases the hyperphosphorylation of Tau in P301L mice model

Noralyn Manucat-Tan, Larisa Bobrovskaya, Yan Jiang Wang, Xin Fu Zhou

Research output: Contribution to journalMeeting Abstractpeer-review

Abstract

p75NTR, a neurotrophin receptor is found to be involved in amyloid beta pathology and tau hyperphosphorylation in patients and animal model with Alzheimer’s disease (AD). However, the mechanism on how p75NTR is involved in tau phosphorylation remains unclear. The extracellular domain (ECD) of p75NTR was found to block amyloid beta toxicity and attenuate tau hyperphosphorylation. The ligand-binding region in the extracellular domain of p75NTR was knocked out in pR5 (P301L) mice model to determine its function in tau hyperphosphorylation.
Original languageEnglish
Pages (from-to)P769
Number of pages1
JournalAlzheimer's & Dementia
Volume12
Issue number7S, Part 15
DOIs
Publication statusPublished - Jul 2016
Externally publishedYes
EventAlzheimer’s Association International Conference 2016 - Toronto, Canada
Duration: 22 Jul 201628 Jul 2016

Keywords

  • p75NTR
  • ligand binding
  • Tau hyperphophorylation
  • P301L tau transgenic mouse
  • Extracellular

Fingerprint

Dive into the research topics of 'Knockout of p75NTR ligand- binding domain decreases the hyperphosphorylation of Tau in P301L mice model'. Together they form a unique fingerprint.

Cite this